Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

r>(unaudited; in thousands, except per share data)Three Months EndedSix Months EndedDec. 31,Sep. 30,Dec. 31,Dec. 31, Dec. 31,20122012201120122011GAAP net income$
41,927$
75,606$
56,253$
7,533$
41,715Adjustments:Research and Development share-based compensation (2)

2,7672,5901,7015,3573,239General and Administrative share-based compensation (2)

1,5035766752,0791,3014,2703,1662,3767,4364,540Non-GAAP net income$
46,197$
78,772$
58,629$
24,969$
46,255GAAP net income per share - basic$
.60$
.09$
.82$
.69$
.61Share-based compensation expense

0.060.040.030.100.07Non-GAAP net income per share - basic$
.66$
.13$
.85$
.79$
.68GAAP net income per share - diluted$
.56$
.02$
.78$
.580.58Share-based compensation expense

0.060.040.040.100.07Non-GAAP net income per share - diluted$
.62$
.06$
.82$
.68$
.65(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our financial statements prepared in accordance with GAAP.(2) All share-based compensation was excluded for the non-GAAP analysis.
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Vala Sciences was recently awarded ... Agency (EPA). This new contract was awarded for ... tests designed to assess the effect of chemical ... connections between neurons (synapses), which are critical for ... by environmental pollutants likely contributes to a variety ...
(Date:7/29/2014)... MA (PRWEB) July 30, 2014 ... (UC) and collaboration company, is proud to announce ... account management positions in their Boston, Charleston and ... response to the increased demand for hosted solutions, ... operational efficiency and reduce cost. , SoundConnect was ...
(Date:7/29/2014)... , July 29, 2014   Sequenom, Inc. ... that provides innovative genetic analysis solutions, and Mayo ... laboratory services in the United States ... testing patents and applications. "We have great ... patient care, and we welcome the opportunity to partner ...
(Date:7/29/2014)... of researchers has created a new way of ... These surfaces, made by self-assembly of carbon nanotubes, ... including controllable mechanical stiffness and strength, or the ... , "We have demonstrated that mechanical forces can ... three-dimensional microstructures, and that we can independently control ...
Breaking Biology Technology:U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3SoundConnect Organization and Culture is Evolving 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4A new way to make microstructured surfaces 2
... small-molecule ... -, - Lead compound AEG40826 works synergistically with HGS TRAIL receptor ... drugs -, - IAP inhibitors also show promise alone and in ... cancer agents across broad range of cancers -, ROCKVILLE, Md. and MONTREAL, ...
... Inc. (OTC Bulletin Board: NWBO; AIM: NWBS ... Lonza Group AG has,withdrawn all claims of ... NWBT DCVax(R) products other than DCVax(R)-Prostate.,Lonza had ... infringed,certain gene expression technology patents held by ...
... Helix BioPharma Corp.,(TSX, FSE: "HBP") today announced ... for gross proceeds of CDN$16,867,200., About ... is a biopharmaceutical company specializing in,the field ... developing innovative,products for the prevention and treatment ...
Cached Biology Technology:Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 2Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 3Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 4Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 5Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs 6Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 2Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 3Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 4Helix BioPharma closes $16.9 million private placement of common shares 2
(Date:7/30/2014)... been awarded the Scientific Committee on Antarctic Research,s ... , SCAR, an inter-disciplinary international science body, initiates, ... in the Antarctic region, and on the role ... The organisation also provides scientific advice about Antarctica ... the region. , The medal is open internationally ...
(Date:7/30/2014)... the roughly 3,000 pieces is still in its infant ... will be of major significance. "Amazingly often, we are ... Fushun amber that we found in Baltic amber," explained ... Baltic amber comes from the Baltic Sea region, which ... finds are, e.g., the coastal regions of Mecklenburg, Poland ...
(Date:7/29/2014)... BELLINGHAM, Washington, USA The advanced optical methods and ... are driving a revolution in the neurosciences were the ... published by SPIE, the international society for optics and ... of the BRAIN Initiative in the United States, and ... vision for and provide examples of the impact that ...
Breaking Biology News(10 mins):Chinese mosquitos on the Baltic Sea 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3
... science prize was today awarded to a researcher who is looking ... someone in a noisy place, such as a party or bar, ... these situations. , Not being able to hear a person's voice ... most common problems for Britain's nine million people with a hearing ...
... Houston, Texas have found two bacterial muscle infections common ... the emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), according ... of Clinical Infectious Diseases, now available online. , Staphylococcus ... the skin or in the nose of a quarter ...
... two inexpensive technologies that may be able to prevent ... E. coli in contaminated spinach. , Together, these technologies ... first method uses a laser to detect and identify ... faster and one-tenth as expensive as current technology. ...
Cached Biology News:Train your brain to hear your friends at a party 2Train your brain to hear your friends at a party 3Train your brain to hear your friends at a party 4Study shows antibiotic-resistant bacteria responsible for increase in muscle infections 2Researchers develop technologies to devour food pathogens 2Researchers develop technologies to devour food pathogens 3
... Maxi Kit provides a fast and simple ... Triton X-100 and other detergents from ... using Norgens patented protein resin as an ... processing 0.25 - 8 mg of either ...
Values of steady state parameters for enzyme activities are determined....
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... Nucleic acid hybridization Preparation Reconstitution: ... BSA, 50 mg ficoll and ... 5 ml of water yields ... molecular biology Density: 1.00 g/mL ...
Biology Products: